Microglia Process α‐Synuclein Fibrils and Enhance their Pathogenicity in a TREM2‐Dependent Manner
Source abstract
Abstract
Abstract Parkinson's disease (PD) is characterized by the deposition of misfolded α‐synuclein (α‐syn) in the brain. Converging evidence indicates that the intracellular transmission and subsequent templated amplification of α‐syn are involved in the onset and progression of PD. However, the molecular mechanisms underlying the cell‐to‐cell transmission of pathological α‐syn remain poorly understood. Microglia is highly activated in the brains of PD patients. Here, it is shown that depletion of microglia slows the spread of pathological α‐syn pathology in mice injected with α‐syn fibrils. Microglia phagocytose α‐syn fibrils and transform them into more toxic species. The phagocytosis of α‐syn fibrils by microglia is partially mediated by triggering a receptor expressed on myeloid cells 2 (TREM2), a transmembrane protein expressed on the surface of microglia. The endocytosed α‐syn fibrils are then cleaved by the lysosomal proteinase asparagine endopeptidase (AEP) to generate truncated α‐syn 1–103 fibrils with enhanced seeding activity. Knockout of TREM2 and AEP impedes the endocytosis and cleavage of α‐syn fibrils, respectively. The results demonstrate that TREM2‐mediated phagocytosis of α‐syn fibrils by microglia and subsequent AEP‐mediated cleavage of α‐syn fibrils contribute to the spread of α‐syn in the brain. Blocking either of these two steps attenuates the progression of α‐syn pathology.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Neuroinflammation and Neurodegeneration Mechanisms · Parkinson's Disease Mechanisms and Treatments · Neurological Disease Mechanisms and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Neurology Renmin Hospital of Wuhan University Wuhan 430060 China
Frontier Science Center for Immunology and Metabolism Medical Research Institute Wuhan University Wuhan 430071 China
Faculty of Life and Health Sciences Shenzhen Institute of Advanced Technology Shenzhen 518035 China
TaiKang Center for Life and Medical Sciences Wuhan University Wuhan 430000 China
Funding
National Key Research and Development Program of China · National Natural Science Foundation of China
References (61)
Show source-provided references
1. 10.1016/S0140-6736(14)61393-310.1016/S0140-6736(14)61393-3 ↗
2. 10.1056/NEJM2003ra02000310.1056/NEJM2003ra020003 ↗
3. 10.1212/WNL.17.5.42710.1212/WNL.17.5.427 ↗
4. 10.1016/S1474-4422(16)30230-710.1016/S1474-4422(16)30230-7 ↗
5. 10.1126/science.125555510.1126/science.1255555 ↗
6. 10.1016/j.brainres.2015.06.00210.1016/j.brainres.2015.06.002 ↗
7. 10.1038/ncb74810.1038/ncb748 ↗
8. 10.1042/BCJ2016049810.1042/BCJ20160498 ↗
9. 10.1186/s40035-015-0049-610.1186/s40035-015-0049-6 ↗
10. 10.1073/pnas.040697610210.1073/pnas.0406976102 ↗
11. 10.1038/nsmb.343310.1038/nsmb.3433 ↗
12. 10.1038/s41593-018-0235-910.1038/s41593-018-0235-9 ↗
13. 10.1186/s40478-021-01131-810.1186/s40478-021-01131-8 ↗
14. 10.3390/cells1002037510.3390/cells10020375 ↗
15. 10.1016/j.molmed.2012.03.00210.1016/j.molmed.2012.03.002 ↗
16. 10.3389/fncel.2018.0028210.3389/fncel.2018.00282 ↗
17. 10.3389/fncel.2018.0024710.3389/fncel.2018.00247 ↗
18. 10.1111/jnc.1422210.1111/jnc.14222 ↗
19. 10.1016/j.neurobiolaging.2007.04.00610.1016/j.neurobiolaging.2007.04.006 ↗
20. 10.1038/nn.413210.1038/nn.4132 ↗
21. 10.3389/fimmu.2021.79503610.3389/fimmu.2021.795036 ↗
22. 10.3389/fneur.2019.0125210.3389/fneur.2019.01252 ↗
23. 10.1016/j.jmb.2017.04.00410.1016/j.jmb.2017.04.004 ↗
24. 10.1186/s12974-020-01878-210.1186/s12974-020-01878-2 ↗
25. 10.1038/s41582-018-0072-110.1038/s41582-018-0072-1 ↗
26. 10.1038/nature1763010.1038/nature17630 ↗
27. 10.1080/00207454.2016.126407210.1080/00207454.2016.1264072 ↗
28. 10.1016/j.neuron.2014.02.04010.1016/j.neuron.2014.02.040 ↗
29. 10.1126/science.122715710.1126/science.1227157 ↗
30. 10.1016/j.cell.2013.11.03010.1016/j.cell.2013.11.030 ↗
31. 10.1038/s41531-021-00272-w10.1038/s41531-021-00272-w ↗
32. 10.4049/jimmunol.204.Supp.64.210.4049/jimmunol.204.Supp.64.2 ↗
33. 10.1038/ncomms1474010.1038/ncomms14740 ↗
34. 10.3389/fnagi.2021.76078110.3389/fnagi.2021.760781 ↗
35. 10.1096/fj.04-2751com10.1096/fj.04-2751com ↗
36. 10.1038/sj.bjp.070716710.1038/sj.bjp.0707167 ↗
37. 10.1093/brain/awaa09010.1093/brain/awaa090 ↗
38. 10.1186/s13024-019-0335-310.1186/s13024-019-0335-3 ↗
39. 10.1096/fj.201900992R10.1096/fj.201900992R ↗
40. 10.1016/j.expneurol.2018.01.01610.1016/j.expneurol.2018.01.016 ↗
41. 10.1074/jbc.M30593020010.1074/jbc.M305930200 ↗
42. 10.1016/S0014-5793(98)01574-910.1016/S0014-5793(98)01574-9 ↗
43. 10.1038/s41422-018-0075-x10.1038/s41422-018-0075-x ↗
44. 10.7554/eLife.3640210.7554/eLife.36402 ↗
45. 10.1038/s41586-020-2317-610.1038/s41586-020-2317-6 ↗
46. 10.1038/s41586-020-1984-710.1038/s41586-020-1984-7 ↗
47. 10.1038/s41586-018-0104-410.1038/s41586-018-0104-4 ↗
48. 10.1038/nature1454710.1038/nature14547 ↗
49. 10.1186/s40478-021-01288-210.1186/s40478-021-01288-2 ↗
50. 10.1074/jbc.M30274220010.1074/jbc.M302742200 ↗
51. 10.1038/nm.370010.1038/nm.3700 ↗
52. 10.1038/nprot.2014.14310.1038/nprot.2014.143 ↗
53. 10.1016/j.cell.2013.05.05710.1016/j.cell.2013.05.057 ↗
54. 10.1016/j.neuron.2011.08.03310.1016/j.neuron.2011.08.033 ↗
55. 10.1074/mcp.M113.03159110.1074/mcp.M113.031591 ↗
56. 10.1093/nar/gkw109910.1093/nar/gkw1099 ↗
57. 10.1039/C8FO00964C10.1039/C8FO00964C ↗
58. Miedel C. J. · J. Vis. Exp. · 2017
59. 10.1186/s13059-017-1382-010.1186/s13059-017-1382-0 ↗
60. 10.1016/j.csbj.2021.06.04310.1016/j.csbj.2021.06.043 ↗
61. 10.1093/brain/awr14910.1093/brain/awr149 ↗